Posted by Shawn. T. on October 17, 2005, at 11:53:08
In reply to NRP104 - D-amphetamine bonded with Lysine?, posted by tecknohed on October 16, 2005, at 7:44:19
Taking it intranasally or intravenously will not result in a sudden, large increase in the concentration of d-amphetamine in the blood. This is because the breakdown of NRP104 to d-amphetamine will be limited by the availability of gastrointestinal enzymes.
On New River's website (http://www.nrpharma.com/products/NRP104.htm), they state that "We reported the results from our first Phase 3 trial on May 23, 2005. A second Phase 3 efficacy trial, as well as clinical abuse liability studies, are underway. We anticipate filing an NDA on NRP104 for the treatment of pediatric populations diagnosed with ADHD by the end of 2005."
Shawn
poster:Shawn. T.
thread:567520
URL: http://www.dr-bob.org/babble/20051017/msgs/568130.html